Inflammatory Rosacea Clinical Trial
Official title:
Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel Group Study of 0444 Gel
The aim of this trial is to assess the efficacy of Metronidazole Topical Gel 1% in the
Treatment of Inflammatory Lesions of Rosacea.
Treatment medication will be administered as follows: A thin film of gel will be applied and
rubbed into the entire face once daily for a period of 70 days.
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment